Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.
about
Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapyAdvances in the management of squamous cell carcinoma of the head and neck.Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer.Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.A model and nomogram to predict tumor site origin for squamous cell cancer confined to cervical lymph nodesEliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of lifeDefinitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy.Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.The impact of reduced-volume, intensity-modulated radiation therapy on disease control in nasopharyngeal carcinoma.Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.Impact of postoperative daily image-guided intensity-modulated radiotherapy on overall and local progression-free survival in patients with oral cavity cancerPatterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinomaHead and neck squamous cell carcinoma: optimizing the therapeutic index.Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control.Defining the target for radiotherapy of head and neck cancer.Dementia Risk in Irradiated Patients With Head and Neck CancerIMRT for head and neck cancer: reducing xerostomia and dysphagia.Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.Ipsilateral irradiation for well lateralized carcinomas of the oral cavity and oropharynx: results on tumor control and xerostomiaClinical effectiveness, toxicity, and failure patterns of helical tomotherapy for postoperative oral cavity cancer patients.Organ-sparing radiation therapy for head and neck cancer.Emerging understanding of dosimetric factors impacting on dysphagia and nutrition following radiotherapy for oropharyngeal cancer.Current challenges in clinical target volume definition: tumour margins and microscopic extensions.Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization.Decreased 3D observer variation with matched CT-MRI, for target delineation in Nasopharynx cancer.Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.A novel setup approach for helical tomotherapy in head and neck cancer: A case report.Head and neck lymph node region delineation with image registration.Emphasizing conformal avoidance versus target definition for IMRT planning in head-and-neck cancerElective nodal dose of 60 Gy or 50 Gy in head and neck cancers: A matched pair analysis of outcomes and toxicity.Clinical and dosimetric evaluation of RapidArc versus standard sliding window IMRT in the treatment of head and neck cancer.Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity.Therapeutic treatment plan optimization with probability density-based dose prescription.Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results.Optimizing localization accuracy in head and neck, and brain radiotherapy.Using CT or MRI to assess locoregional spread to determine the radiotherapy target of hypopharyngeal carcinoma.Marginal recurrences after selective targeting with intensity-modulated radiotherapy for oral tongue cancer.
P2860
Q33667338-E2F17FDD-1454-4160-8424-C9478E39828EQ33720431-C0F6EE30-97D4-4EFC-9A0A-2E9724D98034Q33804565-7B1EA913-8E13-4711-AC0D-D063744DA69AQ33870454-E2B0FE9F-692E-40AB-A48D-BC48F61CEB71Q34516457-55276B53-4823-4FA7-B406-483405D81DCAQ34642109-EFDE021B-B99C-4FA0-B8F7-FADC8C5C3ACFQ35019239-9144BFAC-91DA-46AE-B154-625E8A1ED139Q35081204-068F6511-40E4-4DDB-9CB3-4A0E8590DCE0Q35534813-C5C0D2BE-1264-4FF3-86A7-C2088988D2D8Q35547568-E8C254CC-82A3-4507-AEAC-455D86BF98D9Q35731886-627856AB-C29F-4F83-A9FC-4D936782AFFFQ35932428-C729DF9E-3FBF-49F3-9F8B-4F10F3F69A1EQ35948237-B265C4F5-75DF-4AB5-B7A5-C7F049DB7FE0Q36185629-DB0A1955-49AC-4CBC-838C-3000C070C649Q36463319-A9189152-28C5-455B-98AE-520878E0EDD0Q36922981-1E4CC6B5-4B11-49E9-88ED-E05DDF08E7BBQ36963752-71445127-1BDA-415E-8B99-0B741D92C3C2Q37016708-E07A046C-3457-4D1C-900C-C100CE874FA3Q37187245-5E640C3E-C148-45CE-BC8D-B97A0AF1162CQ37333035-075DA646-9D09-41A0-A5B6-E4A2A2A3017EQ37341282-22AA1DB4-9A87-42E3-9C88-441822B93C2DQ37641859-50402989-FA50-4D39-8764-A97CA340C5F1Q37905536-FBF4A631-F5A5-44B2-9CBD-5849B08A2E0DQ38021433-AA73ED36-A9F8-4CD2-AC30-6A0A21D2DD85Q38045432-20DF0E0C-270D-457A-8A94-5E6203438A9DQ38802836-D064BA78-7739-4EA1-A862-8021A3648B8DQ39713470-EC5EB145-BDA2-4E12-80BC-845EAC3BDBEBQ41183357-A58DE854-1E86-44AB-9BA8-91285A0B009FQ41778134-D02C7D05-9B0C-42B0-860A-DD0CF76BF584Q41808616-180E4AFC-7902-4C90-8A9F-5AA94BC54A6FQ42176933-27DFD0A8-AAC7-4B06-A718-C20EC8ED2817Q43379639-A663CAEC-8265-44C4-8DE2-04FF63AD5934Q43848717-A17DFCFB-3DFC-481E-8AEB-B8DFA2345400Q44997973-5CEC4F6E-4ED1-43F4-B4D1-797D02E1AB5CQ45346918-3ECE2694-A6E5-4070-AD1C-03963027D3B6Q46182215-52585644-6285-4AB1-8324-A8487206804CQ47628191-020BFC2B-4A6B-4F16-906B-4D432C625EAAQ48565944-E5338C1A-3D49-4401-B5A3-94965A834B20Q53146584-B7D9A83D-5297-4F3B-B9D8-F7A1C1EE467DQ53246917-87F71943-0A8B-4650-80AD-1D596D1F9102
P2860
Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Determination and delineation ...... nitive and postoperative IMRT.
@en
Determination and delineation ...... nitive and postoperative IMRT.
@nl
type
label
Determination and delineation ...... nitive and postoperative IMRT.
@en
Determination and delineation ...... nitive and postoperative IMRT.
@nl
prefLabel
Determination and delineation ...... nitive and postoperative IMRT.
@en
Determination and delineation ...... nitive and postoperative IMRT.
@nl
P2093
P1476
Determination and delineation ...... initive and postoperative IMRT
@en
P2093
Binh N Tran
Franz J Wippold
James F Dempsey
K S Clifford Chao
P304
P356
10.1016/S0360-3016(02)02881-X
P407
P577
2002-08-01T00:00:00Z